Jeffrey Watts, DO
Orthopaedic Surgery · Transfer, PANPI 1043524424
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,750 of the $6,519 with a category attached, or 72.9%. IKON Spine LLC accounts for 72.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $4,757 and has fallen 95.3% since, to $226 in 2025.
Across 22 payments — averaging $296.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IKON Spine LLC$5K
- Encore Medical, LP$500
- Stryker$294
- Peerless Surgical Inc.$241
- Miach Orthopaedics, Inc.$156
- BD$152
- plus $425 from 7 others
What the payments were for
- Consulting fees$4,75073%
- Travel & lodging$5008%
- Food & beverage$1,26919%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IKON Spine LLC | 1 | $4,750 |
| Encore Medical, LP | 1 | $500 |
| Stryker | 2 | $294 |
| Peerless Surgical Inc. | 2 | $241 |
| Miach Orthopaedics, Inc. | 1 | $156 |
| BD | 1 | $152 |
| Providence Medical Technology, Inc. | 1 | $126 |
| Si-bone, Inc. | 1 | $97 |
| Abbott | 3 | $58 |
| Medtronic | 3 | $46 |
| Orthofix Medical, Inc. | 3 | $40 |
| Globus Medical | 2 | $32 |
| Mid-atlantic Surgical Systems, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cervical and titanium-coated implants$4,750
- DJO SURGICAL$1,000
- ARISTA AH FLEXITIP$152
- ALPHAVENT$148
- OMEGA$147
How this compares
$6,519 in reported general payments places this provider in the 60th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 81 | $523 |
| Gabapentin | 27 | $250 |
| Cephalexin | 30 | $165 |
| Tramadol Hcl | 29 | $62 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $31 |
| Meloxicam | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Transfer
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Jonathan GarinoMalvern$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.